MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call [Yahoo! Finance]
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair [Yahoo! Finance]
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely [Yahoo! Finance]